Internal Medicine - Issue 9/2010

Original Contributions

901

The normalized smoothness index and parametric population RDH index of losartan in patients with newly diagnosed hypertension and metabolic syndrome

I. Řiháček, P. Fráňa, D. Schwarz, M. Plachý, M. Souček

910

Our experience with endoscopic drainage of pancreatic pseudocysts

Bohuslav Kianička, I. Novotný, M. Souček, I. Řiháček, J. Špác

Reviews

915

Cardiovascular morbidity in patients after treatment for testicular cancer

M. Valentová, B. Mladosievičová

920

Rivaroxaban and factor Xa inhibitors in clinical practice

M. Penka

Case Reports

927

Hereditary angioedema – neglected diagnosis

P. Králíčková, E. Burešová, T. Freiberger, I. Tachecí

60th Birthday - Andrej Dukat MD, Csc., FESC

946

Gastroenteropatic neuroendocrine tumors: multidisciplinary approach in therapy

S. Kiňová, Ľ. Kekeňák, E. Kováčová, M. Koreň

951

Arterial hypertension with orthostatic hypotension

B. Krahulec, Z. Bartošová

955

Immunotherapy and long‑term chemoprophylaxis in prevention of recurrent urinary infections in women

S. Krčméry, J. Hromec, Z. Gábrišová, R. Tahotný

961

Adrenal incidentalomas – is the present management rational?

I. Lazúrová

967

Serum lipoprotein profile in newly recognized arterial hypertension. The role of atherogenic lipoproteins in the pathogenesis of disease

S. Oravec, A. Dukát, P. Gavornik, M. Čaprdna, M. Kučera

972

Statin myopathy – rarity or reality?

D. Pella

977

Glycaemia control in critically ill patients is justified and effective

J. Rybka

988

Heart and kidneys – a fatal relationship

P. Solík, E. Goncalvesová

995

Hypertension in patients with diabetes mellitus

M. Souček

1000

Metabolic syndrome and aortic stiffness

A. Šimková, J. Bulas, J. Murín, K. Kozlíková, I. Janiga

1005

Is our management of patients with claudicatio intermittens correct?

V. Štvrtinová

Internal Medicine

2010 Issue 9